<DOC>
	<DOCNO>NCT00234065</DOCNO>
	<brief_summary>The purpose study investigate efficacy cilostazol prevent recurrence cerebral infarction safety long-term administration drug ( 100 mg , twice daily ) patient cerebral infarction ( exclude cardiogenic cerebral embolism ) multi-center , double-blind , parallel-group comparison aspirin ( 81 mg , daily ) .</brief_summary>
	<brief_title>Post-marketing Study Cilostazol ( Cilostazol Stroke Prevention Study 2 )</brief_title>
	<detailed_description />
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Cerebral Infarction</mesh_term>
	<mesh_term>Aspirin</mesh_term>
	<mesh_term>Cilostazol</mesh_term>
	<criteria>1 . Patients stable medical condition 182 day ( 26 week ) occurrence cerebral infarction 2 . Patients infarctrelated foci detect Xray CT scan MRI 3 . Patients age 20 80 year ( inclusive ) time consent 4 . Patients none follow cardiac disease may associate cardiogenic cerebral embolism : mitral stenosis , prosthetic heart valve , endocarditis , myocardial infarction within 6 week occurrence , ventricular aneurysm , endocardial thrombosis , mitral valve prolapse ( patient less 45 year age cause identify ) , atrial fibrillation , sick sinus syndrome , idiopathic cardiomyopathy , patent foramen ovale 5 . Patients without asymptomatic cerebral infarction 6 . Patients neither undergone schedule undergo percutaneous transluminal angioplasty revascularization treatment cerebral infarction 7 . Patients without severe disturbances/impairments follow occurrence cerebral 1 . Patients hemorrhage bleeding tendency ( hemophilia , capillary fragility , intracranial hemorrhage , hemorrhage digestive tract , hemorrhage urinary tract , hemoptysis , hemorrhage vitreous body ) 2 . Pregnant , possibly pregnant , nursing woman 3 . Patients ischemic heart failure 4 . Patients peptic ulcer 5 . Patients severer blood disorder 6 . Patients severe hepatic renal 7 . Patients malignant neoplasm patient receive therapy malignant neoplasm within 5 year prior enter study 8 . Patients history hypersensitivity salicylic acid formulation ingredient cilostazol tablet 9 . Patients aspirin asthma ( asthma attack induce nonsteroidal antiinflammatory analgesic agent ) history aspirin asthma 10 . Patients treat ticlopidine hydrochloride 11 . Patients participate another study investigational drug 12 . Patients otherwise judged inappropriate inclusion study investigator</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>June 2011</verification_date>
</DOC>